Effect of recombinant human erythropoietin treatment on echocardiographic parameters of chronic haemodialysis patients

Basit Öğe Kaydı
dc.contributor.authorSagcan, A
dc.contributor.authorOnen, F
dc.contributor.authorTerzioglu, E
dc.contributor.authorBasci, A
dc.date.accessioned2019-10-27T18:19:26Z
dc.date.available2019-10-27T18:19:26Z
dc.date.issued2001
dc.departmentEge Üniversitesien_US
dc.identifier.endpage345en_US
dc.identifier.issn0195-668X
dc.identifier.startpage345en_US
dc.identifier.urihttps://hdl.handle.net/11454/35666
dc.identifier.volume22en_US
dc.identifier.wosWOS:000170988301322en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherW B Saunders Co Ltden_US
dc.relation.ispartofEuropean Heart Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEffect of recombinant human erythropoietin treatment on echocardiographic parameters of chronic haemodialysis patientsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu